FrancophonIA/ELRC3.0 huggingface dataset:
English: 1 pre-filled syringe (0.5 ml) without needle 10 pre-filled syringes (0.5 ml) without needle 50 pre-filled syringes (0.5 ml) without needle 1 pre-filled syringe (0.5 ml) with 1 needle 10 pre-filled syringes (0.5 ml) with 10 needles 1 pre-filled syringe (0.5 ml) with 2 needles 10 pre-filled syringes (0.5 ml) with 20 needles
Danish: 1 fyldt injektionssprøjte (0,5 ml) uden nål 10 fyldte injektionssprøjter (0,5 ml) uden nål 50 fyldte injektionssprøjter (0,5 ml) uden nål 1 fyldt injektionssprøjte (0,5 ml) med 1 nål 10 fyldte injektionssprøjter (0,5 ml) med 10 nåle 1 fyldt injektionssprøjte (0,5 ml) med 2 nåle 10 fyldte injektionssprøjter (0,5 ml) med 20 nåle
English: Data on concomitant administration of Hexyon with a meningococcal C conjugate vaccine or a meningococcal group A, C, W-135 and Y conjugate vaccine have shown no clinically relevant interference in the antibody response to each of the antigens.
Danish: Data for samtidig administration af Hexyon og konjugeret meningokok C-vaccine eller en meningokok gruppe A, C, W-135 og Y-konjugeret vaccine har ikke vist nogen klinisk relevant påvirkning af antistofresponset på de enkelte antigener.
English: Otherwise, post-vaccination antibody concentration should be ≥ pre immunisation level.
Danish: Ellers bør antistofkoncentrationen efter vaccination være ≥ niveauet før vaccination
English: Pack size of 1 or 10 pre-filled syringes with or without needle.
Danish: Pakningsstørrelse på 1 eller 10 fyldte injektionssprøjter med eller uden nål.
English: Vaccination with Hexyon is contraindicated if the individual has experienced an encephalopathy of unknown aetiology, occurring within 7 days following prior vaccination with a pertussis containing vaccine (whole cell or acellular pertussis vaccines).
Danish: Vaccination med Hexyon er kontraindiceret, hvis individer har oplevet encefalopati af ukendt ætiologi inden for 7 dage efter tidligere vaccination med pertussis vaccine (helcelle- eller acellulære pertussis vacciner).
English: Where a dose of hepatitis B vaccine is given at birth, Hexyon can be used for supplementary doses of hepatitis B vaccine from the age of six weeks.
Danish: Hvis en dosis hepatitis B-vaccine er indgivet ved fødslen, kan Hexyon anvendes som supplerende doser hepatitis B-vaccine fra seks ugers alderen.
English: Common (≥1/100 to <1/10) Uncommon (≥1/1,000 to <1/100) Rare (≥1/10,000 to <1/1,000)
Danish: Ikke almindelig (≥1/1.000 til <1/100) Sjælden
English: OTHER Sanofi Pasteur Europe
Danish: Sanofi Pasteur Europe
English: Hexyon (DTaP-IPV-HB-Hib) is indicated for primary and booster vaccination of infants and toddlers from six weeks of age against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and invasive diseases caused by Haemophilus influenzae type b (Hib).
Danish: Hexyon (DTaP-IPV-HBV-Hib) er indiceret til primær og opfølgende vaccination af spædbørn og børn fra seks uger mod difteri, tetanus, pertussis, hepatitis B, poliomyelitis og invasive sygdomme forårsaget af Haemophilus influenzae type b (Hib).
English: In the absence of hepatitis B vaccination at birth, it is necessary to give a hepatitis B vaccine booster dose.
Danish: Ved manglende hepatitis B-vaccination ved fødslen, er det nødvendigt at administrere en booster-dosis af hepatitis B-vaccine.
English: Multipack: 50 (5 packs of 10) pre-filled syringes (0.5ml) without needle.
Danish: Multipakning: 50 (5 pakker med 10) fyldte injektionssprøjter (0,5ml) uden nål.
English: When a dose of hepatitis B vaccine is given at birth, the sequential infant primary vaccination hexavalent/pentavalent/hexavalent schedule with Hexyon and a pentavalent DTaP-IPV/Hib vaccine can be used in accordance with official recommendations.
Danish: Når en dosis af hepatitis B-vaccine gives ved fødslen, kan det efterfølgende børnevaccinationsprogram hexavalent/pentavalent/hexavalent med Hexyon og en pentavalent DiTeKiPol/Hib-vaccine anvendes i overensstemmelse med officielle anbefalinger.
English: Hexyon (DTaP-IPV-HB-Hib) is a vaccine used to protect against infectious diseases.
Danish: Hexyon (DTaP-IPV-HBV-Hib) er en vaccine.
English: Hexyon helps to protect against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and serious diseases caused by Haemophilus influenzae type b. Hexyon is given to children from six weeks of age.
Danish: Hexyon hjælper med at beskytte mod difteri, stivkrampe, kighoste, leverbetændelse B, polio og alvorlige sygdomme, der stammer fra Haemophilus influenzae type b. Hexyon gives til børn i alderen fra seks uger.
English: Hexyon will not protect against hepatitis infection caused by other agents such as hepatitis A, hepatitis C and hepatitis E or by other liver pathogens.
Danish: Hexyon beskytter ikke mod hepatitis infektion, der stammer fra andre patogener, såsom hepatitis A, hepatitis C og hepatitis E eller andre leverpatogener.
English: • has had an allergic reaction - to the active substances, - to any of the excipients listed in section 6, - to glutaraldehyde, formaldehyde, neomycin, streptomycin or polymyxin B, as these substances are used during the manufacturing process - after previous administration of Hexyon or any other diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B or Hib containing vaccines.
Danish: • har haft en allergisk reaktion - over for de aktive stoffer, - over for et eller flere hjælpestoffer, anført i afsnit 6, - over for glutaraldehyd, formaldehyd, neomycin, streptomycin eller polymyxin B, da disse stoffer anvendes under fremstilllingen, - efter tidligere indgivelse af Hexyon eller andre vacciner mod difteri, tetanus, pertussis, poliomyelitis, hepatitis B eller Hib.
English: Hexyon is available in pack containing 10 vials.
Danish: Hexyon føres i pakning, der indeholder 10 hætteglas.
English: • sudden and serious malaise with drop in blood pressure causing dizziness and loss of consciousness, accelerated heart rate associated with respiratory disorders
Danish: • pludseligt og alvorligt ubehag med blodtryksfald (forårsager svimmelhed og bevidsthedstab) og hurtig i puls forbindelse med luftvejsgener
English: Other side effects not listed above have been reported occasionally with other diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B or Hib containing vaccines and not directly with Hexyon:
Danish: Andre bivirkninger, der ikke er anført herover, er blevet indberettet lejlighedsvis for andre vacciner, der indeholder difteri, tetanus, pertussis, poliomyelitis, hepatitis B eller Hib og ikke direkte Hexyon:
English: Booster vaccination during the second year of life following a three dose primary course
Danish: Booster vaccination i andet leveår efter en primærvaccination på tre doser måneder uger måneder måneder
English: Hexyon in pre-filled syringes EU/1/13/829/002
Danish: Hexyon i fyldte injektionssprøjter EU/1/13/829/002
English: Contents of the pack and other information What Hexyon contains The active substances are per dose (0.5 ml)1: Diphtheria Toxoid not less than 20 IU2
Danish: Aktive stoffer pr. dosis (0,5 ml) Difteri toxoid ikke mindre end 20 IE
English: • Hexyon will not protect against hepatitis infection caused by other agents such as hepatitis A, hepatitis C and hepatitis E.
Danish: • Hexyon beskytter ikke mod hepatitisinfektion, der stammer fra andre smitsomme organismer, f.eks. hepatitis A, hepatitis C og hepatitis E eller andre, der angriber leveren.
English: After a 3-dose primary vaccination with Hexyon, a booster dose should be given.
Danish: Efter primærvaccination med 3 doser Hexyon bør der gives en booster-dosis.
English: Hexyon is available in multipack comprising 5 cartons, each containing 10 pre-filled syringes without attached needle.
Danish: Hexyon føres i multipakning, der består af 5 æsker, der hver indeholder 10 fyldte injektionssprøjter uden monteret nål.
English: 40 D antigen units5
Danish: 40 D antigen-enheder
English: 1 Adsorbed on aluminium hydroxide, hydrated (0.6 mg Al3+)
Danish: 1 Adsorberet på aluminiumhydroxid, hydreret (0,6 mg Al3+)
English: • Uncommon side effects (may affect up to 1 in 100 people) are: - allergic reaction - a lump (nodule) at the injection site - high fever (temperature 39.6°C or higher)
Danish: • Ikke almindelige bivirkninger (kan påvirke op til 1 ud af 100 mennesker) er: - allergisk reaktion - knude på injektionsstedet - høj feber (temperatur på 39,6 °C eller højere)
English: After a 2-dose primary vaccination with Hexyon, a booster dose must be given.
Danish: Efter primærvaccination med 2 doser Hexyon skal der gives en booster-dosis.
English: Adsorbed on aluminium hydroxide, hydrated (0.6 mg Al
Danish: Adsorberet på aluminiumhydroxidhydrat (0.6 mg Al
English: Hexyon suspension for injection in pre-filled syringe Hexyon suspension for injection
Danish: Hexyon injektionsvæske, suspension i fyldt injektionssprøjte Hexyon injektionsvæske, suspension
English: Hexyon suspension for injection
Danish: Hexyon injektionsvæske, suspension
English: Pharmaco-therapeutic group: Vaccines, Bacterial and viral vaccines combined, ATC code: J07CA09 The immunogenicity of Hexyon in children over 24 months of age has not been studied in clinical trials.
Danish: Farmakoterapeutisk klassifikation: Vacciner, kombinerede bakterielle og virale vacciner, ATC-kode: J07CA09.
English: No data are available in older children (see sections 4.8 and 5.1)
Danish: Der er ingen tilgængelige data for større børn (se pkt.
English: Anti-diphtheria (≥ 0.01 IU/ml) Anti-tetanus (≥ 0.01 IU/ml) Anti PT (Seroconversion‡‡) (Vaccine response§) Anti FHA (Seroconversion‡‡) (Vaccine response§)
Danish: Anti-difteri ( 0,01 IE/ml) Anti-tetanus ( 0,01 IE/ml) Anti-PT (Serokonversion ‡‡) (Vaccinerespons§) Anti-FHA (Serokonversion ‡‡) (Vaccinerespons§)
English: Table 2: Seroprotection/Seroconversion rates* one month after booster vaccination with Hexyon Antibody Thresholds
Danish: Tabel 2: Serobeskyttelse/Serokonversionsrate én måned efter en booster vaccination med
English: • Temporary inflammation of nerves causing pain, paralysis and sensitivity disorders (GuillainBarré syndrome) and severe pain and decreased mobility of arm and shoulder (brachial neuritis) have been reported after administration of a tetanus containing vaccine.
Danish: • Midlertidig inflammation af nerver, der forårsager smerter, lammelse og føleforstyrrelser (Guillain-Barré syndrom) eller alvorlig smerte og formindsket bevægelighed i arm og skulder (brachial neuritis) er blevet indberettet efter at have fået en vaccine, der indeholder tetanus (en inaktiveret form for stivkrampe).
English: 10 pre-filled syringes (0.5ml) without needle.
Danish: 10 fyldte injektionssprøjter (0,5ml) uden nål.
English: Hexyon is provided as a suspension for injection in vial (0.5 ml).
Danish: Hexyon foreligger som injektionsvæske, suspension i hætteglas (0,5 ml).
English: Sanofi Pasteur Europe, 14 Espace Henry Vallée, 69007 Lyon, France
Danish: Sanofi Pasteur Europe, 14 Espace Henry Vallée, 69007 Lyon, Frankrig
English: Hypersensitivity to the active substances, to any of the excipients listed in section 6.1, to trace residuals (glutaraldehyde, formaldehyde, neomycin, streptomycin and polymyxin B), to any pertussis vaccine, or after previous administration of Hexyon or a vaccine containing the same components or constituents.
Danish: 6.1, over spor af residualstoffer (glutaraldehyd, formaldehyd, neomycin, streptomycin og polymyxin B), over for en pertussis vaccine, over for en tidligere administration af Hexyon eller en vaccine, der indeholder de samme indholdsstoffer eller bestanddele.
English: Disodium hydrogen phosphate, potassium dihydrogen phosphate, trometamol, saccharose, essential amino acids including L-phenylalanine, sodium hydroxide and/or acetic acid and/or hydrochloric acid (for pH adjustment), and water for injections.
Danish: Dinatriumhydrogenphosphat, kaliumdihydrogenphosphat, trometamol, saccharose, essentielle aminosyrer, herunder L-phenyalanin, natriumhydroxid og/eller eddikesyre og/eller saltsyre (til pH justering) samt vand til injektionsvæsker.
English: Hexyon is provided as a suspension for injection in pre-filled syringe (0.5 ml).
Danish: Hexyon foreligger som injektionsvæske, suspension i fyldt injektionssprøjte (0,5 ml).
English: What you need to know before Hexyon is given to your child
Danish: Det skal du vide, før dit barn vaccineres med Hexyon
English: Hexyon in pre-filled syringes
Danish: Hexyon i fyldte injektionssprøjter
English: Hexyon in vials EU/1/13/829/001
Danish: Hexyon i hætteglas EU/1/13/829/001
English: Anti-PRP (≥ 1.0 µg/ml) * Generally accepted surrogates (PT, FHA) or correlates of protection (other components) N = Number of individuals analysed (per protocol set) ** 3, 5 months without hepatitis B vaccination at birth (Finland, Sweden) † 6, 10, 14 weeks with and without hepatitis B vaccination at birth (Republic of South Africa) †† 2, 3, 4 months without hepatitis B vaccination at birth (Finland) ‡ 2, 4, 6 months without hepatitis B vaccination at birth (Mexico) and with hepatitis B vaccination at birth (Costa Rica and Colombia) ‡‡ Seroconversion: minimum 4-fold increase compared to pre-vaccination level (pre-dose 1) § Vaccine response: If pre-vaccination antibody concentration (pre-dose 1) <8 EU/ml, then the post-booster antibody concentration should be ≥8 EU/ml.
Danish: * Generelt accepterede surrogater (PT, FHA) eller korrelater for beskyttelse (andre komponenter) N = Antal analyserede individer (per protokolsæt) ** 3, 5 måneder uden hepatitis B-vaccination ved fødslen (Finland, Sverige) † 6, 10, 14 uger med og uden hepatitis B-vaccination ved fødslen (Sydafrika) †† 2, 3, 4 måneder uden hepatitis B-vaccination ved fødslen (Finland) ‡ 2, 4, 6 måneder uden hepatitis B-vaccination ved fødslen ( Mexico) og med hepatitis B-vaccination ved fødslen (Costa Rica og Colombia) ‡‡ Serokonversion: minimum 4 gange stigning sammenlignet med niveauet før vaccination (før dosis 1) § Vaccinerespons: Hvis antistofkoncentrationen før vaccination (før dosis 1) er <8 EU/ml, skal antistofkoncentrationen efter booster-vaccination være ≥8 EU/ml, ellers skal antistofkoncentrationen efter booster vaccination være ≥ niveauet før vaccination (før dosis 1).
English: Do not use Hexyon if your child:
Danish: Dit barn må ikke blive vaccineret med Hexyon, hvis det
English: Hexyon - Carton for pre-filled syringe with one separate needle.
Danish: Hexyon - Pakning med fyldt injektionssprøjte med én separat nål.
English: Data on concomitant administration of Hexyon with a pneumococcal polysaccharide conjugate vaccine have shown no clinically relevant interference in the antibody response to each of the antigens.
Danish: Data for samtidig administration af Hexyon med en pneumokok polysaccharid konjugeret vaccine har ikke vist nogen klinisk relevant påvirkning af antistofrespons af de enkelte antigener.
English: Hexyon is available in pack containing 1 or 10 pre-filled syringes with 2 separate needles.
Danish: Hexyon føres i pakning, der indeholder 1 eller 10 fyldte injektionssprøjter med 2 separate nåle.
English: (polyradiculoneuritis), facial paralysis, visual disturbances, sudden dimming or loss of vision (optic neuritis), inflammatory disease of brain and spinal cord (central nervous system demyelination, multiple sclerosis) have been reported after administration of a hepatitis B antigen containing vaccine.
Danish: • Sensoriske lidelser i flere nerver eller svaghed i ekstremiteterne (polyradiculitis), ansigtslammelse, synsforstyrrelser, pludselig sløring eller tab af synet (optisk neuritis), inflammatorisk lidelse af hjerne og rygmarv (centralnervesystemsdemyelinisering, multipel sklerose) er indberettet efter injektion af en vaccine, der indeholder et hepatitis B antigen.
English: Hexyon is available in pack containing 1 or 10 pre-filled syringes with 1 separate needle.
Danish: Hexyon føres i pakning, der indeholder 1 eller 10 fyldte injektionssprøjter med 1 separat nål.
English: Hexyon is available in pack containing 1,10 or 50 pre-filled syringes without attached needle.
Danish: Hexyon føres i pakning, der indeholder 1, 10 eller 50 fyldte injektionssprøjter uden monteret nål.
English: Marketing Authorisation Holder: Sanofi Pasteur Europe, 14 Espace Henry Vallée, 69007 Lyon, France
Danish: Indehaver af markedsføringstilladelsen: Sanofi Pasteur Europe, 14 Espace Henry Vallée, 69007 Lyon, Frankrig
English: (optic neuritis), inflammatory disease of brain and spinal cord (central nervous system demyelination, multiple sclerosis) have been reported after administration of a hepatitis B antigen containing vaccine.
Danish: - Perifer neuropati (polyradiculitis, facialisparase), optisk neurit, centralnervesystems-demyelinisering (multipel sklerose) er indberettet efter administration af vaccine, der indeholder et hepatitis B antigen.
English: Anti-PRP (≥ 0.15 µg/ml) * Generally accepted surrogates (PT, FHA) or correlates of protection (other components) N = Number of individuals analysed (per protocol set) ** 3, 5 months without hepatitis B vaccination at birth (Finland, Sweden) † 6, 10, 14 weeks with and without hepatitis B vaccination at birth (Republic of South Africa) †† 2, 3, 4 months without hepatitis B vaccination at birth (Finland) ‡ 2, 4, 6 months without hepatitis B vaccination at birth (Argentina, Mexico, Peru) and with hepatitis B vaccination at birth (Costa Rica and Colombia) ‡‡ Seroconversion: minimum 4-fold increase compared to pre-vaccination level (pre-dose 1) § Vaccine response: If pre-vaccination antibody concentration <8 EU/ml, then the post-vaccination antibody concentration should be ≥ 8 EU/ml.
Danish: N = Antal analyserede individer (per protokolsæt) ** 3, 5 måneder uden hepatitis B-vaccination ved fødslen (Finland, Sverige) † 6, 10, 14 uger med og uden hepatitis B-vaccination ved fødslen (Sydafrika) †† 2, 3, 4 måneder uden hepatitis B-vaccination ved fødslen (Finland) ‡ 2, 4, 6 måneder uden hepatitis B-vaccination ved fødslen (Argentina, Mexico, Peru) og med hepatitis Bvaccination ved fødslen (Costa Rica og Colombia) ‡‡ Serokonversion: minimum 4-folds stigning sammenlignet med niveauet før vaccination (før dosis 1) § Vaccinerespons: Hvis koncentrationen af antistof før vaccination <8 EU/ml, bør antistofkoncentrationen efter vaccination være ≥8 EU/ml.
English: When a hepatitis B vaccine is given at birth, after a 3-dose primary vaccination, Hexyon or a pentavalent DTaP-IPV/Hib vaccine can be administered for the booster.
Danish: Når der gives en hepatitis B-vaccine ved fødslen, kan Hexyon eller en pentavalent DTaP-IPV/HiBvaccine administreres som booster efter en 3-dosis primærvaccination.
English: Hexyon in vials
Danish: Hexyon i hætteglas
English: 5Equivalent antigenic quantity in the vaccine 6 Produced in yeast Hansenula polymorpha cells by recombinant DNA technology
Danish: Fremstillet i Hansenula polymorpha gærceller ved hjælp af rekombinant DNA-teknologi
English: With hepatitis B vaccination at birth Without hepatitis B vaccination at birth 97.2
Danish: Med hepatitis Bvaccination ved fødsel Uden hepatitis Bvaccination ved fødsel
English: METHOD AND ROUTE(S) OF ADMINISTRATION Intramuscular use.
Danish: ANVENDELSESMÅDE OG ADMINISTRATIONSVEJ(E)
English: Multipack of 50 (5 packs of 10) pre-filled syringes without needle.
Danish: Pakningsstørrelse med 50 fyldte injektionssprøjter uden nål Multipakning med 50 (5 pakker med 10) fyldte injektionssprøjter uden nål
English: Data on concomitant administration of a booster dose of Hexyon with measles-mumps-rubella vaccines have shown no clinically relevant interference in the antibody response to each of the antigens.
Danish: Data for samtidig administration af en booster dosis af Hexyon med MFR-vacciner har ikke vist nogen klinisk relevant påvirkning af antistofrespons af de enkelte antigener.
English: Anti-Polio type 1 (≥ 8 (1/dilution))
Danish: Anti-polio type 1 ( 8 (1/fortynding))
English: 0.5 ml suspension in vial (type I glass) with a stopper (halobutyl).
Danish: 0,5 ml injektionsvæske, suspension (type I-glas) med stempelstop (halobutyl).
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Hexyon suspension for injection
Danish: LÆGEMIDLETS NAVN OG ADMINISTRATIONSVEJ(E)
English: What Hexyon is and what it is used for What you need to know before Hexyon is given to your child How to use Hexyon
Danish: Det skal du vide, før dit barn vaccineres med Hexyon Sådan bliver dit barn vaccineret med Hexyon Bivirkninger
English: Very rare (<1/10,000) Not known (cannot be estimated from available data)
Danish: (kan ikke estimeres ud fra tilgængelige data)
English: Pyrexia (body temperature ≥39.6°C)
Danish: Induration på injektionssted Ikke almindelig Knude på injektionssted Pyreksi (legemstemperatur ≥39,6 °C)
English: Nervous system disorders
Danish: Intramuskulær anvendelse.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Hexyon - Carton for pre-filled syringe without needle.
Danish: Hexyon - Pakning med fyldt injektionssprøjte uden nål.
English: CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT 1 dose (0.5 ml)
Danish: INDHOLD ANGIVET SOM VÆGT, VOLUMEN ELLER ANTAL DOSER
English: Nervous system disorders - Brachial neuritis and Guillain-Barré Syndrome have been reported after administration of a tetanus toxoid containing vaccine - Peripheral neuropathy (polyradiculoneuritis, facial paralysis), optic neuritis, central nervous system demyelination (multiple sclerosis) have been reported after administration of a hepatitis B antigen containing vaccine - Encephalopathy/encephalitis
Danish: Nervesystemet - Brakial neuritis og Guillain-Barré syndrom er indberettet efter administration af en vaccine, der indeholder tetanus toxoid.
English: - after previous administration of Hexyon or any other diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B or Hib containing vaccines.
Danish: der indeholder difteri, tetanus, pertussis, poliomyelitis, hepatitis B eller Hib og ikke direkte Hexyon:
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING Hexyon - Carton for vial.
Danish: Hexyon - Pakning til hætteglas.
English: Rash
Danish: Hexyon
English: IM
Danish: e
English: Hexyon - Carton for pre-filled syringe with two separate needles.
Danish: Pakke med 1 eller 10. Hexyon - Pakning med fyldt injektionssprøjte med to separate nåle.
English: Patients should be informed that they have received Revasc.
Danish: Patienterne bør informeres om, at de har fået Revasc.
English: Revasc can cause serious harm to your baby.
Danish: Revasc kan medføre alvorlig skade på Deres barn.
English: Metabolism and elimination
Danish: Metabolisme og elimination
English: It is therefore important to tell your doctor if you are pregnant or planning to become pregnant.
Danish: Det er derfor vigtigt, at De fortæller det til lægen, hvis De er gravid eller planlægger at blive gravid.
English: If you need treatment for longer than 12 days, the doctor may switch you to another similar medicine.
Danish: Hvis De har behov for behandling i mere end 12 dage, kan lægen skifte til en anden lignende medicin.
English: Pack size of 1, 2 or 10.
Danish: Pakningsstørrelser på 1, 2 eller 10
English: It may be necessary to change the dose, to take other precautions, or in some cases to stop taking one of the medicines.
Danish: Det kan være nødvendigt at ændre dosis, at tage andre forholdsregler eller i visse tilfælde ophøre med at tage et af præparaterne.
English: Solvent for parenteral use
Danish: Solvens til parenteralt brug
English: You will be given Revasc as an injection under the skin.
Danish: De vil få Revasc indgivet som en indsprøjtning under huden.
English: Do not use Revasc after the expiry date which is stated on the carton and the pack.
Danish: Brug ikke Revasc efter den udløbsdato, der står på kartonen og pakningen.
English: If a dose of this medicine is missed, it should be given to you as soon as possible.
Danish: Hvis man har sprunget en dosis af denne medicin over, bør De få den snarest muligt.
English: You should not be given Revasc if you are pregnant.
Danish: De må ikke få Revasc, hvis De er gravid.
English: You will be given the first injection within 5 to 15 minutes before the operation.
Danish: De får den første injektion inden for 5-15 minutter før operationen.
English: Usual dosage
Danish: Normal dosering
English: aPTT levels can, however, be reduced by intravenous administration of DDAVP (desmopressin).
Danish: aPTT niveauer kan imidlertid reduceres ved intravenøs administration med DDAVP (desmopressin).